Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT00116389 Org: User:
Start: - End: - Due: -

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00086203 Org: User:
Start: - End: 09/30/07 Due: 09/30/08

Study of Talabostat in Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00083239 Org: User:
Start: - End: - Due: -

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00243204 Org: User:
Start: 01/31/06 End: - Due: -

Study of Talabostat and Cisplatin in Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00083252 Org: User:
Start: - End: - Due: -

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00080080 Org: User:
Start: - End: - Due: -

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00290017 Org: User:
Start: 02/28/06 End: - Due: -